pyrazolanthrone has been researched along with Diabetes Mellitus, Type 2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LH; Chen, V; De, SK; Karin, M; Kitada, S; Kuntzen, C; Machleidt, T; Pavlickova, P; Pellecchia, M; Stebbins, JL | 1 |
| Feng, S; He, J; Li, Q; Ling, H; Song, Z; Wang, Z; Yan, C; Yang, S | 1 |
| Giacca, A; Koulajian, K; Tai, K; Tang, C; Volchuk, A; Yeung, LSN; Zhang, L | 1 |
| Handa, K; Inukai, K; Ishida, H; Katsuta, H; Kitahara, A; Moriya, R; Nishida, S; Ohno, H; Onuma, H; Sakurai, T; Sumitani, Y; Takahashi, K; Tanaka, T | 1 |
| Atsumi, T; Ishida, A; Kurokawa, M; Narumi, K; Sugita, C; Watanabe, H; Watanabe, W; Yoshida, H | 1 |
| Hintze, TH; Huang, A; Kaley, G; Sun, D; Yan, C; Yang, YM | 1 |
6 other study(ies) available for pyrazolanthrone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.
Topics: Adenosine Triphosphate; Amino Acid Motifs; Animals; Binding, Competitive; Cell Line; Chemical and Drug Induced Liver Injury; Consensus Sequence; Cytokines; Diabetes Mellitus, Type 2; Drug Design; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Mimicry; Peptides; Phosphorylation; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 2011 |
Dihydromyricetin alleviates hippocampal ferroptosis in type 2 diabetic cognitive impairment rats via inhibiting the JNK-inflammatory factor pathway.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ferroptosis; Hippocampus; Iron; Rats | 2023 |
Glucose-Induced β-Cell Dysfunction In Vivo: Evidence for a Causal Role of C-jun N-terminal Kinase Pathway.
Topics: Animals; Anthracenes; Diabetes Mellitus, Type 2; Glucose; Glucose Clamp Technique; Homeodomain Proteins; Hyperglycemia; In Vitro Techniques; Insulin; Insulin-Secreting Cells; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 8; Protein Kinase Inhibitors; Rats; RNA, Messenger; Signal Transduction; Trans-Activators | 2018 |
Ghrelin augments the expressions and secretions of proinflammatory adipokines, VEGF120 and MCP-1, in differentiated 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Androstadienes; Animals; Anthracenes; Cell Line; Chemokine CCL2; Chromones; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Ghrelin; Interleukin-10; JNK Mitogen-Activated Protein Kinases; Mice; Morpholines; Oxidative Stress; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Wortmannin | 2015 |
Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anthracenes; Cell Line; Chemokine CCL2; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Obesity; RNA, Messenger; Time Factors | 2014 |
Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice.
Topics: Animals; Anthracenes; Butadienes; Diabetes Mellitus, Type 2; Extracellular Signal-Regulated MAP Kinases; Imidazoles; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mitogen-Activated Protein Kinases; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Leptin; Resveratrol; Signal Transduction; Stilbenes; Superoxides | 2012 |